The expanding demand for precise immunological research and therapeutic development has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using diverse expression platforms, including bacterial hosts, animal cell cultures, and bacu